After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that Exelixis to Webcast Fireside Chats as Part of Investor Conferences in March.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
EXEL belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Exelixis Inc is $7.12B. A total of 2.41 million shares were traded on the day, compared to an average of 2.31M shares.
In the most recent transaction, Haley Patrick J. sold 47,020 shares of EXEL for 21.45 per share on Feb 23 ’24. After the transaction, the EVP, Commercial now owns 384,866 company shares. In a previous transaction on Feb 21 ’24, JOHNSON DAVID EDWARD bought 190,000 shares at 20.70 per share. EXEL shares that Director owns now total 1,100,730.
Among the insiders who sold shares, Haley Patrick J. disposed of 50,000 shares on Dec 14 ’23 at a per-share price of $23.35. This resulted in the EVP, Commercial holding 307,687 shares of EXEL after the transaction. In another insider transaction, Hessekiel Jeffrey sold 25,000 shares at $23.01 per share on Dec 13 ’23. Company shares held by the EVP, General Counsel & Sec now total 533,345.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, EXEL has a high of $24.34 and a low of $17.90.
As of this writing, EXEL has an earnings estimate of $0.23 per share for the current quarter. EPS was calculated based on a consensus of 14 estimates, with a high estimate of $0.47 per share and a lower estimate of $0.11. The company reported an EPS of $0 in the last quarter, which was -100.00% lower than expectations of $0.09.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. EXEL’s latest balance sheet shows that the firm has $1.47B in Cash & Short Term Investments as of fiscal 2021. There were $51.27M in debt and $337.59M in liabilities at the time. Its Book Value Per Share was $7.48, while its Total Shareholder’s Equity was $2.21B.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for EXEL is Buy with a score of 4.63.
